ArticleScience translational medicine2018

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.

Claudio R Scafoglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.